Menu

Home / For Visitors / Exhibitor Product / Vol.136 The Era of "Nuclear Medicine Gold" is Here: Taiwan’s Crisis in Radiopharmaceutical Autonomy—What’s Missing for Resilience Upgrades?

Vol.136 The Era of "Nuclear Medicine Gold" is Here: Taiwan’s Crisis in Radiopharmaceutical Autonomy—What’s Missing for Resilience Upgrades?

Model: Vol.136

Category: Media & Other Services

Exhibitor: GLOBAL BIO & INVESTMENT MONTHLY

Booth No: N009

Characteristic

The half-life determines the drug's lifespan, while the supply chain dictates national competitiveness. As global nuclear medicine accelerates its shift from diagnostic imaging to precision therapy, how far is Taiwan from achieving the goal of "domestic production for domestic use"?

Other Products

Products you may be interested in

Highest Rated Products

TOP